IL6 and stroke disorder: SCFAs have been associated with elevated levels of systemic proinflammatory markers IL-6, TNF-α, vascular cell adhesion molecule-1(VCAM-1), IL-17, and MCP-1 after stroke, which was associated with a high disease burden at discharge and the duration of inpatient recovery (33).